|
Market Closed -
Nasdaq
16:00:00 2026-10-01 EDT
|
5-day change | 1st Jan Change | ||
| 8.270 USD | -4.28% |
|
-8.52% | -66.92% |
| 09-15 | Olema Pharmaceuticals, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-15-2026 01:50 PM | |
| 09-14 | Top Premarket Decliners | MT |
| Market Cap | 724M 643M 601M 548M 1.03B 69.67B 1.05B 7.27B 2.81B 35.48B 2.72B 2.66B 114B | P/E 2026 * |
-3.42x | P/E 2027 * | -3.11x |
|---|---|---|---|---|---|
| Enterprise Value | 594M 527M 493M 449M 846M 57.17B 858M 5.97B 2.31B 29.11B 2.23B 2.18B 93.51B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 100x |
| Free-Float |
98.24% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| OLMA | Delayed | |
CBOE
| OLMA | Real-time |
Last Transcript: Olema Pharmaceuticals, Inc.
| 1 day | -4.28% | ||
| 1 week | -8.52% | ||
| Current month | -4.28% | ||
| 1 month | -21.69% | ||
| 3 months | -31.54% | ||
| 6 months | -45.30% | ||
| Current year | -66.92% |
| 1 week | 8.19 |  | 8.86 |
| 1 month | 8.19 | | 11.18 |
| Current year | 8.19 | | 29.5 |
| 1 year | 6.65 | | 36.26 |
| 3 years | 2.86 | | 36.26 |
| 5 years | 2 | | 36.26 |
| 10 years | 2 | | 60.27 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sean Bohen
CEO | Chief Executive Officer | 59 | 2020-08-31 |
Jason O’Byrne
DFI | Director of Finance/CFO | 57 | 2026-08-10 |
Meghna Chowdary
COO | Chief Operating Officer | - | 2025-12-29 |
| Director | Title | Age | Since |
|---|---|---|---|
Andy Rappaport
BRD | Director/Board Member | 68 | 2012-12-31 |
| Director/Board Member | 37 | 2018-06-30 | |
Graham Walmsley
BRD | Director/Board Member | 39 | 2020-02-29 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/1/26 | Free | Chief Financial Officer | 650,000 | 0.7429% | ||
| 7/24/26 | Sell | Founder | -12,500 | 0.0143% | ||
| 6/18/26 | Free | Director | 29,500 | 0.0338% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.28% | -8.52% | -25.09% | -33.04% | 756M | |
| +4.16% | -0.36% | +49.37% | +94.17% | 74.46B | |
| -0.61% | +0.69% | +36.36% | +82.72% | 60.14B | |
| -2.54% | -0.21% | +6.34% | +31.72% | 48.15B | |
| -3.02% | -5.20% | +27.94% | +32.51% | 44.25B | |
| +0.31% | +3.02% | +348.95% | +643.82% | 43.99B | |
| -1.96% | -0.33% | +7.04% | +99.46% | 41.61B | |
| +3.32% | +3.49% | +11.18% | +51.23% | 29.97B | |
| +4.77% | +6.16% | +36.77% | +22.78% | 29.31B | |
| -4.86% | -10.66% | -26.27% | +330.06% | 24.93B | |
| Average | -0.47% | +1.55% | +47.26% | +135.54% | 39.76B | |
| Weighted average by Cap. | +0.16% | +1.82% | +59.83% | +145.44% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 6.34M 5.63M 5.27M 4.8M 9.04M 611M 9.16M 63.73M 24.67M 311M 23.81M 23.29M 999M |
| Net income | -246M -218M -204M -186M -351M -23.68B -355M -2.47B -957M -12.06B -924M -904M -38.74B | -294M -261M -244M -222M -418M -28.27B -424M -2.95B -1.14B -14.4B -1.1B -1.08B -46.24B |
| Net Debt | -130M -115M -108M -98.3M -185M -12.5B -188M -1.3B -505M -6.37B -488M -477M -20.45B | -86.61M -76.93M -71.94M -65.56M -123M -8.34B -125M -870M -337M -4.25B -325M -318M -13.64B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-01 | US$8.270 | -4.28% | 1,009,505 |
| 26-09-30 | US$8.640 | +1.17% | 1,542,813 |
| 26-09-29 | US$8.540 | -0.81% | 1,081,253 |
| 26-09-28 | US$8.610 | -1.60% | 979,229 |
| 26-09-25 | US$8.750 | -3.21% | 1,382,802 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- OLMA Stock
Select your edition
All financial news and data tailored to specific country editions
